ENTBF
ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. (ENTBF)
$
08About ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. (ENTBF)
Entheon Biomedical Corp. operates as a biotechnology research and development company. The firm engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.04
Market cap
1.1M
Dividend yield
0.00%
Volume
--
Avg. volume
381
P/E ratio
-2.57
ENTHEON BIOMEDICAL CORP by ENTHEON BIOMEDICAL CORP. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.29
52 Week Low
$0.04
Market cap
1.1M
Dividend yield
0.00%
Volume
--
Avg. volume
381
P/E ratio
-2.57